Pro Share Advisors LLC Dyne Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $39.7 Billion
- Q3 2024
A detailed history of Pro Share Advisors LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,182 shares of DYN stock, worth $301,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,182
Previous 15,170
39.63%
Holding current value
$301,208
Previous $535,000
42.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DYN
# of Institutions
207Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$114 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$97.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$97 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$96.9 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $736M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...